Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00540_DB00615_nanopub.RAAjJ22_S23-oLzwJ_Ciq3LHIe-v90kffUJwtNzL3gFw0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00540_DB00615 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00540_DB00615 label "DDI between Nortriptyline and Rifabutin - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, nortriptyline, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if rifabutin is initiated, discontinued or dose changed. [drugbank_resource:DB00540_DB00615]" assertion.
- drugbank_resource:DB00540_DB00615 identifier "drugbank_resource:DB00540_DB00615" assertion.
- drugbank_resource:DB00540_DB00615 title "DDI between Nortriptyline and Rifabutin - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, nortriptyline, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if rifabutin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00615 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00540_DB00615 assertion.
- drugbank:DB00540 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00540_DB00615 assertion.